Point72 Asset Management’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,584,300
| Closed | -$11.6M | – | 1368 |
|
2024
Q1 | $11.6M | Sell |
1,584,300
-1,904,863
| -55% | -$14M | 0.03% | 556 |
|
2023
Q4 | $13M | Buy |
3,489,163
+3,415,762
| +4,654% | +$12.8M | 0.03% | 509 |
|
2023
Q3 | $156K | Buy |
73,401
+63,265
| +624% | +$134K | ﹤0.01% | 1185 |
|
2023
Q2 | $48.2K | Buy |
+10,136
| New | +$48.2K | ﹤0.01% | 1089 |
|
2020
Q4 | – | Sell |
-151,564
| Closed | -$6.06M | – | 921 |
|
2020
Q3 | $6.06M | Sell |
151,564
-175,272
| -54% | -$7.01M | 0.03% | 485 |
|
2020
Q2 | $11.2M | Buy |
+326,836
| New | +$11.2M | 0.07% | 293 |
|
2020
Q1 | – | Sell |
-782,783
| Closed | -$15.3M | – | 837 |
|
2019
Q4 | $15.3M | Sell |
782,783
-397,306
| -34% | -$7.78M | 0.08% | 289 |
|
2019
Q3 | $18.3M | Buy |
1,180,089
+586,589
| +99% | +$9.11M | 0.11% | 226 |
|
2019
Q2 | $12M | Buy |
593,500
+93,500
| +19% | +$1.9M | 0.06% | 304 |
|
2019
Q1 | $8.79M | Buy |
+500,000
| New | +$8.79M | 0.04% | 375 |
|